Appeals are built using structured medical logic, insurance requirements, andin paid planshuman review and support from an appeal specialist
The key practical difference is that tirzepatide requires dose escalation over several weeks, while semaglutide can begin at therapeutic doses immediately
1,2 If initiating a GLP-1 RA in a patient with T2D for glucose-lowering effect and/or for organ protection in a patient on background DPP-4 inhibitor therapy, it is recommended that the DPP-4 inhibitor be discontinued
However, because semaglutide affects digestion and causes weight loss, your levothyroxine requirements are very likely to change
The semaglutide group also experienced more gastrointestinal events, like nausea and constipation, than the placebo group
To qualify for Wegovy for weight loss, youll typically need a BMI of 30 or higher (obesity) or a BMI of 27 or higher (overweight) with a weight-related health condition